Table 5.
Comparison of gastrointestinal symptoms between gastroparesis patients on chronic opioids and patients with no opioid use trial[10,11,27]
| GpCO | GpNO | P value | |
| Episodes of vomiting in last 1 wk | 13.0 (1.0-7.0) | 11.0 (0.0-3.0) | 0.002 |
| Hours of nausea/day in last 1 wk | 17.0 (3.0-18.0) | 14 (1.5-12.0) | 0.037 |
| Total number of BMs in last 1 wk | 14.0 (2.0-7.0) | 4.0 (2.0-7.0) | 0.714 |
| AP one of the symptoms (%) | 84.1% (37/43) | 85.2% (132/155) | 0.861 |
| Duration of AP (yr) | 12.0 (0.5-4.0) | 11.5 (0.7-4.5) | 0.526 |
| Location of most severe AP | Umbilical 41.7% (15/36) | Epigastric 44.2% (57/129) | 0.863 |
| AP wakes up at night (%) | 78.1% (7/32) | 57.3% (71/124) | 0.031 |
| AP worse with meals (%) | 76.5% (26/34) | 80.0% (100/125) | 0.508 |
1
Results with non-normal distribution. Results expressed as median with interquartile range, and percentage as appropriate. AP: Abdominal pain; BMs: Bowel movements; GpCO: Gastroparesis patients on chronic opioids; GpNO: Gastroparesis patients not on opioids.